Here’s a quick snapshot of the latest around SMR (NuScale Power) stock as of the end of May 2026, based on recent coverage and price data.
Direct answer
- SMR (NuScale Power) has been seeing mixed sentiment in late May 2026, with active headlines around licensing progress, potential AI-driven demand, and partnerships that could influence deployment timelines. Prices have fluctuated within a range roughly from the high single digits to low teens in 2026, with a recent price near the $11–$12 area and a price target suggesting potential upside from current levels. Note that sentiment and targets vary by source and analyst.
Key recent sources and what they indicate
- Real-time price and overview: SMR trades on NYSE with price figures updated throughout the day; the stock has shown volatility as investors weigh licensing milestones against execution risk. This context helps explain why price targets from several analysts suggest meaningful upside but with caution about execution risk.[2]
- News flow and catalysts: Coverage highlights licensing progress, NRC interactions, and partnerships (e.g., TVA/ENTRA1–style arrangements) as potential catalysts for future deployments and revenue, even as earnings and revenue recent trends remain a point of worry for some analysts. These factors are often cited as the drivers behind short-term moves and longer-term value debates.[3]
- Market sentiment and price targets: Several outlets and analysts publish updated price targets in the mid-teens, reflecting an expectation of upside contingent on licensing momentum and project wins, contrasted with some notes about near-term profitability challenges.[4][5]
What to watch next
- Licensing milestones with the NRC: Any positive updates on Part 52 approvals and licensing timelines can act as a major stock catalyst.
- Deployment announcements: New partnerships or announced deployment plans (even pilots) tend to move SMR stock more than isolated financial results.
- Revenue trajectory: Sustained revenue growth or improved visibility into project awards would be a key long-term driver.
Would you like me to pull the most up-to-date single-source summaries (with the exact latest price, the most recent earnings call notes, and the consensus price target) and present them in a concise bullet list with inline citations? I can also generate a quick chart of SMR price over the last 6–12 months if you want a visual view.